MIXED PLEURAL MESOTHELIOMA WITH MYOCARDIAL METASTASIS IN BALB/C MOUSE

MIXED PLEURAL MESOTHELIOMA WITH MYOCARDIAL METASTASIS IN BALB/C MOUSE

Mixed pleural mesothelioma is uncommon spontaneous tumor in laboratory mice. The case of this tumor in BALB/c mouse has been described in the paper. It is essential that myocardial metastasis has been observed. Differential diagnostics between pleural mesothelioma, pleural dissemination of bronchoal...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. N. Manskikh, O. S. Gancharova
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	spontaneous tumors in laboratory mice mixed pleural mesothelioma
Online Access:	https://www.siboncoj.ru/jour/article/view/56
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Incidence and Outcomes of Brain Metastasis in Pleural Mesothelioma in the Era of Immunotherapy
by: Margaret Stalker, MD, et al.
Published: (2025-05-01)

A Diagnostic Approach to Malignant Pleural Mesothelioma
by: Avinash Aujayeb, et al.
Published: (2025-06-01)

The presence of pleural effusion is an independent prognostic factor in patients with malignant pleural mesothelioma
by: Haoyu Wang, et al.
Published: (2025-01-01)

Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands
by: Illaa Smesseim, et al.
Published: (2025-07-01)

Hyperthermic Intrathoracic Chemoperfusion and the Role of Adjunct Immunotherapy for the Treatment of Pleural Mesothelioma
by: Susan Luozheng Kong, et al.
Published: (2025-05-01)

Fibulin-3 in plasma and pleural effusion as a biomarker of mesothelioma
by: Adamic Katja, et al.
Published: (2025-06-01)

Exploring RNA cargo in extracellular vesicles for pleural mesothelioma detection
by: Agnieszka Kraft, et al.
Published: (2025-02-01)

Diagnostic value of microRNAs for malignant pleural mesothelioma: A mini‐review
by: Yan‐Qiu Han, et al.
Published: (2021-01-01)

Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study
by: Ziya Kalkan, et al.
Published: (2025-03-01)

Twice as Effective? Pressurized Intra-Thoracic Aerosol Chemotherapy: New Frontiers in Pleural Mesothelioma
by: Maria Giovanna Mastromarino, et al.
Published: (2025-06-01)

Recent Advances in Medical Treatment of Malignant Pleural Mesothelioma
by: Jie YANG, et al.
Published: (2025-05-01)

Neuroimaging informatics framework for analyzing rare brain metastasis patterns in pleural mesothelioma using hybrid PET CT
by: Sumit Kumar Agrawal, et al.
Published: (2025-06-01)

Molecular Insights into Pleural Mesothelioma: Unveiling Pathogenic Mechanisms and Therapeutic Opportunities
by: Teodora Zahiu, et al.
Published: (2025-05-01)

Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
by: Saima Jamil Farooqi, et al.
Published: (2024-12-01)

The Role of Surgery in Pleural Mesothelioma: A Journey through the Evidence, MARS 2 and Beyond
by: Avinash Aujayeb, et al.
Published: (2025-04-01)

Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma
by: Berta Mosleh, et al.
Published: (2025-03-01)

Extra-pleural pneumonectomy: How I teach itCentral Message
by: Phil Honest, BSc, et al.
Published: (2024-10-01)

Miliary Mesothelioma
by: Dujinthan Jayabalan, et al.
Published: (2025-03-01)

The Role of Epithelial–Mesenchymal Transition in Malignant Pleural Mesothelioma: From Pathogenesis to Diagnosis and Treatment
by: Dimitrios E. Magouliotis, et al.
Published: (2025-04-01)

Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment
by: Sabine Schmid, MD, et al.
Published: (2024-12-01)

Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?
by: Alberto Revelant, et al.
Published: (2025-04-01)

Immune-related gene risk model establishment and role of key gene FUCA1 in malignant pleural mesothelioma
by: Lin Shi, et al.
Published: (2025-05-01)

Immune checkpoint inhibitor-associated polyneuropathy in malignant pleural mesothelioma: A case report
by: Mehdi Kashani, et al.
Published: (2025-09-01)

Genome-wide DNA methylation analysis reveals a unique methylation pattern for pleural mesothelioma compared to healthy pleura and other lung diseases
by: Janah Vandenhoeck, et al.
Published: (2024-12-01)

EXPERIENCE IN DIAGNOSING RARE DIGESTIVE SYSTEM NEOPLASMS IN LABORATORY MICE
by: V. N. Manskikh, et al.
Published: (2016-02-01)

Volatile organic compounds in exhaled human breath for the diagnosis of malignant pleural mesothelioma: a meta-analysis
by: Tingting Zhao, et al.
Published: (2025-05-01)

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma
by: Sophie Rovers, et al.
Published: (2025-12-01)

Role of HEG1 and Claudin-4 Immunohistochemistry in the Differential Diagnosis of Lung Adenocarcinoma from Malignant Mesothelioma in Pleural Effusion Cytology
by: Aziza E. ABDELRAHMAN, et al.
Published: (2025-05-01)

Research status and prospects of treatment for malignant pleural mesothelioma
by: ZHAO Kaile, WANG Lei, GENG Jianxiong, CUI Chengwei, YU Yan
Published: (2025-03-01)

Transcriptional landscape of pleural mesothelioma patients in relation to NF2 gene mutational status
by: Carlos Orozco-Castaño, et al.
Published: (2025-06-01)

Discordant Response to Nivolumab Plus Ipilimumab and Identification of BRAF V600E Mutation in Biphasic Malignant Pleural Mesothelioma: Case Report
by: Olivia Wilkins, DO, et al.
Published: (2025-05-01)

Sarcomatoid diffuse pleural mesothelioma in an 80-year-Old woman with long-term response to nivolumab plus ipilimumab: A case report
by: Yukiko Yoshida, et al.
Published: (2025-01-01)

The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma
by: Andrew C. Kidd, et al.
Published: (2024-01-01)

Intracavitary cisplatin-fibrin followed by irradiation improved tumor control compared to the single treatments in a mesothelioma rat modelCentral MessagePerspective
by: Michaela B. Kirschner, PhD, et al.
Published: (2024-12-01)

EXPERIENCE IN DIAGNOSING RARE BLOOD SYSTEM TUMORS IN LABORATORY MICE
by: V. N. Manskikh, et al.
Published: (2016-02-01)

M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma
by: Tetsuya Fukui, et al.
Published: (2025-04-01)

The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis
by: Nadiye Sever, et al.
Published: (2025-01-01)

A Case of Duodenal Metastasis From Malignant Pleural Mesothelioma Diagnosed by Gastrointestinal Endoscopy Following Progressive Anemia During Salvage Chemotherapy
by: Naruhiko Ichiyama, et al.
Published: (2025-06-01)

An Interesting Case of Recurrent Pleural Effusion: A Case Report
by: Sanket P Mistry, et al.
Published: (2025-05-01)

Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma
by: I. C. Salaroglio, et al.
Published: (2024-12-01)